BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36707423)

  • 21. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases.
    Tang S; Onuma K; Deb P; Wang E; Lytwyn A; Sur M; Daya D
    Int J Gynecol Pathol; 2012 Mar; 31(2):103-10. PubMed ID: 22317864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fallopian tube: the dark face of pelvic carcinogenesis].
    Watkin E; Devouassoux-Shisheboran M
    Ann Pathol; 2011 Oct; 31(5):345-52. PubMed ID: 21982240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?
    Gao FF; Bhargava R; Yang H; Li Z; Zhao C
    Hum Pathol; 2013 Aug; 44(8):1534-43. PubMed ID: 23465279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices.
    Samimi G; Trabert B; Duggan MA; Robinson JL; Coa KI; Waibel E; Garcia E; Minasian LM; Sherman ME
    Gynecol Oncol; 2018 Mar; 148(3):515-520. PubMed ID: 29395311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas.
    Horn LC; Kafkova S; Leonhardt K; Kellner C; Einenkel J
    Int J Gynecol Pathol; 2013 Jul; 32(4):339-44. PubMed ID: 23722505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of precursor lesions (P53 signature, SCOUT, STIL, STIC) in fallopian tubes resected for non-neoplastic causes.
    Tewari S; Misra V; Kumar V; Mishra RR; Yadav K; Paridhi ; Sangma H
    Indian J Pathol Microbiol; 2022; 65(3):610-616. PubMed ID: 35900489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up.
    Blok F; Dasgupta S; Dinjens WNM; Roes EM; van Beekhuizen HJ; Ewing-Graham PC
    Gynecol Oncol; 2019 May; 153(2):326-334. PubMed ID: 30894273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions.
    Wu RC; Wang P; Lin SF; Zhang M; Song Q; Chu T; Wang BG; Kurman RJ; Vang R; Kinzler K; Tomasetti C; Jiao Y; Shih IM; Wang TL
    J Pathol; 2019 May; 248(1):41-50. PubMed ID: 30560554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO.
    Pölcher M; Hauptmann S; Fotopoulou C; Schmalfeldt B; Meinhold-Heerlein I; Mustea A; Runnebaum I; Sehouli J
    Arch Gynecol Obstet; 2015 Jul; 292(1):231-4. PubMed ID: 25914073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.
    Cass I; Walts AE; Barbuto D; Lester J; Karlan B
    Gynecol Oncol; 2014 Sep; 134(3):492-7. PubMed ID: 25026639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy.
    Ayres C; Ratnayake G; McNally O; Quinn M
    Int J Gynecol Cancer; 2017 May; 27(4):703-707. PubMed ID: 28399030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary.
    Gutkin DW; Shurin MR; El Azher MA; Shurin GV; Velikokhatnaya L; Prosser D; Shin N; Modugno F; Stemmer P; Elishaev E; Lokshin A
    Cancer Biomark; 2019; 26(4):471-479. PubMed ID: 31658047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO).
    Stanciu PI; Ind TEJ; Barton DPJ; Butler JB; Vroobel KM; Attygalle AD; Nobbenhuis MAE
    J Ovarian Res; 2019 May; 12(1):50. PubMed ID: 31128592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.
    Carlson JW; Miron A; Jarboe EA; Parast MM; Hirsch MS; Lee Y; Muto MG; Kindelberger D; Crum CP
    J Clin Oncol; 2008 Sep; 26(25):4160-5. PubMed ID: 18757330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.
    Howitt BE; Hanamornroongruang S; Lin DI; Conner JE; Schulte S; Horowitz N; Crum CP; Meserve EE
    Am J Surg Pathol; 2015 Mar; 39(3):287-93. PubMed ID: 25581732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
    Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
    Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of tumor cells of serous tubal intraepithelial carcinoma (STIC) in cervical smears and rapid development of the ovarian involvement: A case report.
    Shintaku M; Taniguchi H; Yamamoto Y; Kono F; Sumitomo M
    Diagn Cytopathol; 2018 Nov; 46(11):945-949. PubMed ID: 30375200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
    Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V
    Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sectioning and extensively examining the fimbriated end (SEE-FIM) of the fallopian tube in routine practices, is it worth the effort?
    Laokulrath N; Warnnissorn M; Chuangsuwanich T; Hanamornroongruang S
    J Obstet Gynaecol Res; 2019 Mar; 45(3):665-670. PubMed ID: 30506766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.